Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that the…